PMC:7696151 / 80577-80746 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2386","span":{"begin":99,"end":107},"obj":"Gene"},{"id":"2396","span":{"begin":138,"end":144},"obj":"Species"},{"id":"2415","span":{"begin":120,"end":123},"obj":"Chemical"},{"id":"2445","span":{"begin":155,"end":168},"obj":"Disease"}],"attributes":[{"id":"A2386","pred":"tao:has_database_id","subj":"2386","obj":"Gene:56208"},{"id":"A2396","pred":"tao:has_database_id","subj":"2396","obj":"Tax:10090"},{"id":"A2415","pred":"tao:has_database_id","subj":"2415","obj":"MESH:D006886"},{"id":"A2445","pred":"tao:has_database_id","subj":"2445","obj":"MESH:D001943"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This hypothesis has been evaluated by Brönnimann, et al. [157], administering by intravenously TAT–Beclin 1 peptide and HCQ (65 mg/kg) in murine models of breast cancer."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T184","span":{"begin":155,"end":168},"obj":"Phenotype"}],"attributes":[{"id":"A184","pred":"hp_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"This hypothesis has been evaluated by Brönnimann, et al. [157], administering by intravenously TAT–Beclin 1 peptide and HCQ (65 mg/kg) in murine models of breast cancer."}

{"project":"LitCovid-sentences","denotations":[{"id":"T516","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This hypothesis has been evaluated by Brönnimann, et al. [157], administering by intravenously TAT–Beclin 1 peptide and HCQ (65 mg/kg) in murine models of breast cancer."}